A phase II trial testing the thermal dose parameter CEM43° T90 as a predictor of response in soft tissue sarcomas treated with pre-operative thermoradiotherapy

Search and browse 5 million articles across 13,000 publications from over 250 publishers by publication, subject, publisher, author or keyword.